This initiative, conducted at the Arthritis Center at Brigham and Women’s Hospital, had three distinct but related steps:

  1. Development of an internally endorsed treatment pathway.
  2. Detailed retrospective Chart reviews.
  3. Improved documentation of functional status and disease activity measures.

Citation for the Full-text Article

Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP. A quality improvement approach to rheumatoid Arthritis management with biologic disease-modifying antirheumatic drugs: assessing variability in a treatment pathway. J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.

Latest News from CRICO

Get all your medmal and patient safety news here.
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm